TY - JOUR
T1 - Hypaque and steroids in the treatment of sudden sensorineural hearing loss
AU - HUANG, TSUN‐SHENG ‐S
AU - CHAN, SHU‐TOA ‐T
AU - HO, TZE‐LI ‐L
AU - SU, JEN‐LIANG ‐L
AU - LEE, FEI‐PENG ‐P
PY - 1989/2
Y1 - 1989/2
N2 - While the origins of sudden sensorineural hearing loss remain unproven and treatment empirical, the most appropriate therapy remains a matter of controversy. In this paper we have analysed the current forms of treatment, i.e. diatrizoate meglumine, steroids and a vasodilator. The results suggest that although several related factors were shown to indicate a good prognosis regardless of the therapy, none of the currently available regimens produces consistently better results than the spontaneous recovery rate of 65% reported by Mattox & Simmons.1
AB - While the origins of sudden sensorineural hearing loss remain unproven and treatment empirical, the most appropriate therapy remains a matter of controversy. In this paper we have analysed the current forms of treatment, i.e. diatrizoate meglumine, steroids and a vasodilator. The results suggest that although several related factors were shown to indicate a good prognosis regardless of the therapy, none of the currently available regimens produces consistently better results than the spontaneous recovery rate of 65% reported by Mattox & Simmons.1
KW - sudden sensorineural hearing loss idoopathic
UR - http://www.scopus.com/inward/record.url?scp=0024550630&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024550630&partnerID=8YFLogxK
U2 - 10.1111/j.1365-2273.1989.tb00336.x
DO - 10.1111/j.1365-2273.1989.tb00336.x
M3 - Article
C2 - 2920456
AN - SCOPUS:0024550630
VL - 14
SP - 45
EP - 51
JO - Clinical Otolaryngology
JF - Clinical Otolaryngology
SN - 1749-4478
IS - 1
ER -